BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24931950)

  • 1. Ischemic digital ulcers affect hand disability and pain in systemic sclerosis.
    Mouthon L; Carpentier PH; Lok C; Clerson P; Gressin V; Hachulla E; Bérezné A; Diot E; Khau Van Kien A; Jego P; Agard C; Duval-Modeste AB; Sparsa A; Puzenat E; Richard MA;
    J Rheumatol; 2014 Jul; 41(7):1317-23. PubMed ID: 24931950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function.
    Mouthon L; Carpentier PH; Lok C; Clerson P; Gressin V; Hachulla E; Bérezné A; Diot E; Van Kien AK; Jego P; Agard C; Duval-Modeste AB; Sparsa A; Puzenat E; Richard MA;
    Semin Arthritis Rheum; 2017 Jun; 46(6):759-766. PubMed ID: 28214014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.
    Hachulla E; Clerson P; Launay D; Lambert M; Morell-Dubois S; Queyrel V; Hatron PY
    J Rheumatol; 2007 Dec; 34(12):2423-30. PubMed ID: 17985402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
    Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
    Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis.
    Mouthon L; Mestre-Stanislas C; Bérezné A; Rannou F; Guilpain P; Revel M; Pagnoux C; Guillevin L; Fermanian J; Poiraudeau S
    Ann Rheum Dis; 2010 Jan; 69(1):214-7. PubMed ID: 19221115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers.
    Bérezné A; Seror R; Morell-Dubois S; de Menthon M; Fois E; Dzeing-Ella A; Nguyen C; Hachulla E; Guillevin L; Poiraudeau S; Mouthon L
    Arthritis Care Res (Hoboken); 2011 Feb; 63(2):277-85. PubMed ID: 20824802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)].
    Riccardi MT; Chialà A; Lannone F; Grattagliano V; Covelli M; Lapadula G
    Reumatismo; 2007; 59(2):135-9. PubMed ID: 17603693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval.
    Agard C; Carpentier PH; Mouthon L; Clerson P; Gressin V; Bérezné A; Diot E; Jego P; Lok C; Sparsa A; Chatelus E; Van Kien AK; Quéré I; Sibilia J; Hachulla E
    Scand J Rheumatol; 2014; 43(5):398-402. PubMed ID: 24720440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bosentan in clinical practice for treating digital and other ischemic ulcers in Spanish patients with systemic sclerosis: IBER-DU cohort study.
    Roman Ivorra JA; Simeon CP; Alegre Sancho JJ; Egurbide MV; Castillo MJ; Lloria X; Fonollosa V
    J Rheumatol; 2011 Aug; 38(8):1631-5. PubMed ID: 21632679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis.
    Fiori G; Galluccio F; Braschi F; Amanzi L; Miniati I; Conforti ML; Del Rosso A; Generini S; Candelieri A; Magonio A; Goretti R; Rasero L; Matucci-Cerinic M
    Clin Exp Rheumatol; 2009; 27(3 Suppl 54):51-4. PubMed ID: 19796562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunctional arteriovenous anastomoses in hands of systemic sclerosis patients with digital ulcers.
    Bergersen TK; Hoffmann-Vold AM; Midtvedt Ø; Gran JT; Mørk C; Toska K; Elstad M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-53-9. PubMed ID: 24847906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study.
    Cutolo M; Herrick AL; Distler O; Becker MO; Beltran E; Carpentier P; Ferri C; Inanç M; Vlachoyiannopoulos P; Chadha-Boreham H; Cottreel E; Pfister T; Rosenberg D; Torres JV; Smith V;
    Arthritis Rheumatol; 2016 Oct; 68(10):2527-39. PubMed ID: 27111549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital ulcers: overt vascular disease in systemic sclerosis.
    Steen V; Denton CP; Pope JE; Matucci-Cerinic M
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii19-24. PubMed ID: 19487218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis.
    Bruni C; Ngcozana T; Braschi F; Pucci T; Piemonte G; Benelli L; Poli M; Suliman YA; Guiducci S; Bellando-Randone S; Balduzzi S; Grotts J; Denton CP; Rasero L; Montecucco C; Furst DE; Matucci-Cerinic M
    J Rheumatol; 2019 Jun; 46(6):603-608. PubMed ID: 30442833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis.
    Avouac J; Riemekasten G; Meune C; Ruiz B; Kahan A; Allanore Y
    J Rheumatol; 2015 Oct; 42(10):1801-7. PubMed ID: 26233500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
    Matucci-Cerinic M; Denton CP; Furst DE; Mayes MD; Hsu VM; Carpentier P; Wigley FM; Black CM; Fessler BJ; Merkel PA; Pope JE; Sweiss NJ; Doyle MK; Hellmich B; Medsger TA; Morganti A; Kramer F; Korn JH; Seibold JR
    Ann Rheum Dis; 2011 Jan; 70(1):32-8. PubMed ID: 20805294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.